rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
2007-12-19
|
pubmed:abstractText |
The interleukin-6 (IL-6) -174 G/C polymorphism has been reported to determine IL-6 levels and contribute to the development of cardiovascular disorders. The aim of our study was to evaluate the effect of the IL-6 -174 G/C polymorphism on hemostatic or inflammatory markers in patients with peripheral arterial occlusive disease (PAOD), a common manifestation of obliterative atherosclerosis.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0392-9590
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
26
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
318-23
|
pubmed:meshHeading |
pubmed-meshheading:18091699-Acute-Phase Proteins,
pubmed-meshheading:18091699-Adult,
pubmed-meshheading:18091699-Arterial Occlusive Diseases,
pubmed-meshheading:18091699-Blood Coagulation Factors,
pubmed-meshheading:18091699-Case-Control Studies,
pubmed-meshheading:18091699-Female,
pubmed-meshheading:18091699-Genotype,
pubmed-meshheading:18091699-Humans,
pubmed-meshheading:18091699-Interleukin-6,
pubmed-meshheading:18091699-Male,
pubmed-meshheading:18091699-Middle Aged,
pubmed-meshheading:18091699-Peripheral Vascular Diseases,
pubmed-meshheading:18091699-Polymorphism, Genetic
|
pubmed:year |
2007
|
pubmed:articleTitle |
Association between inflammatory markers and the interleukin-6 -174 G/C polymorphism is abolished in peripheral arterial occlusive disease.
|
pubmed:affiliation |
Department of Medicine, Jagiellonian University School of Medicine, Cracow, Poland.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|